ProShares UltraShort Nasdaq Biotechnology (BIS)

34.47
NASDAQ : Financial
Prev Close 34.56
Day Low/High 34.04 / 34.92
52 Wk Low/High 25.26 / 54.01
Avg Volume 239.60K
Exchange NASDAQ
Shares Outstanding 1.68M
Market Cap 58.23M
Div & Yield N.A. (N.A)

Latest News

Interesting BIS Put And Call Options For December 18th

Interesting BIS Put And Call Options For December 18th

Investors in Proshares UltraShort Nasdaq Biotechnology saw new options begin trading this week, for the December 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIS options chain for the new December 18th contracts and identified one put and one call contract of particular interest.

ProShares UltraShort Nasdaq Biotechnology Experiences Big Outflow

ProShares UltraShort Nasdaq Biotechnology Experiences Big Outflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares UltraShort Nasdaq Biotechnology where we have detected an approximate $59.1 million dollar outflow -- that's a 26.2% decrease week over week (from 5,334,998 to 3,934,998). START SLIDESHOW:Click here to find out which 9 other ETFs experienced notable outflows » The chart below shows the one year price performance of BIS, versus its 200 day moving average: Looking at the chart above, BIS's low point in its 52 week range is $24.12 per share, with $72.15 as the 52 week high point — that compares with a last trade of $38.19.

IIROC Trade Resumption - BIS

IIROC Trade Resumption - BIS

IIROC Trading Halt - BIS

IIROC Trading Halt - BIS

ProShares Expands Largest Lineup Of Leveraged And Inverse ETFs

ProShares Expands Largest Lineup Of Leveraged And Inverse ETFs

ProShares, a premier provider of alternative ETFs, today announced the launch of six new geared ETFs.

BIS Crowded With Sellers

BIS Crowded With Sellers

In trading on Thursday, shares of the ProShares UltraShort Nasdaq Biotechnology ETF entered into oversold territory, changing hands as low as $27.81 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator used to measure momentum on a scale of zero to 100.

IIROC Trade Resumption - BIS

IIROC Trade Resumption - BIS

BIS vs. IBB is The 'Chart of the Day'

BIS vs. IBB is The 'Chart of the Day'

The BIS vs. IBB is the OptionsProfits 'Chart of the Day.'

IIROC Trading Halt - BIS

IIROC Trading Halt - BIS

First Week of December 20th Options Trading For Proshares UltraShort Nasdaq Biotechnology (BIS)

First Week of December 20th Options Trading For Proshares UltraShort Nasdaq Biotechnology (BIS)

Investors in Proshares UltraShort Nasdaq Biotechnology saw new options begin trading this week, for the December 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIS options chain for the new December 20th contracts and identified one put and one call contract of particular interest.

ProShares Announces ETF Share Splits

ProShares Announces ETF Share Splits

ProShares, a premier provider of alternative ETFs, announced today reverse share splits on ten of its ETFs.

4 Stocks Rising on Unusual Volume

4 Stocks Rising on Unusual Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

First Week of BIS June 21st Options Trading

First Week of BIS June 21st Options Trading

Investors in Proshares UltraShort Nasdaq Biotechnology saw new options become available this week, for the June 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIS options chain for the new June 21st contracts and identified one put and one call contract of particular interest.

Biotech in a Bull Market, Not a Bubble: StockTwits

Biotech in a Bull Market, Not a Bubble: StockTwits

A majority of investors on StockTwits.com say the biotech sector is oversold. And they're looking to buy in for a bounce-back.

BIS Crosses Critical Technical Indicator

BIS Crosses Critical Technical Indicator

In trading on Thursday, shares of the Proshares UltraShort Nasdaq Biotechnology ETF entered into oversold territory, changing hands as low as $20.581 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator used to measure momentum on a scale of zero to 100.

BIS Crosses Critical Technical Indicator

BIS Crosses Critical Technical Indicator

In trading on Friday, shares of the Proshares UltraShort Nasdaq Biotechnology ETF entered into oversold territory, changing hands as low as $22.38 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator used to measure momentum on a scale of zero to 100.

Shares Of BIS Now Oversold

Shares Of BIS Now Oversold

In trading on Friday, shares of the Proshares UltraShort Nasdaq Biotechnology ETF entered into oversold territory, changing hands as low as $25.13 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator used to measure momentum on a scale of zero to 100.

BIS Crowded With Sellers

BIS Crowded With Sellers

In trading on Friday, shares of the Proshares UltraShort Nasdaq Biotechnology ETF entered into oversold territory, changing hands as low as $30.52 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator used to measure momentum on a scale of zero to 100.

Proshares UltraShort Nasdaq Biotechnology (BIS) Enters Oversold Territory

Proshares UltraShort Nasdaq Biotechnology (BIS) Enters Oversold Territory

In trading on Tuesday, shares of the Proshares UltraShort Nasdaq Biotechnology ETF entered into oversold territory, changing hands as low as $43.97 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator used to measure momentum on a scale of zero to 100.

ProShares Announces ETF Share Splits

ProShares Announces ETF Share Splits

ProShares, the nation's fourth most successful exchange traded fund (ETF) company, 1 announced today share splits on six of its ETFs and reverse share splits on 11 of its ETFs.

ProShares Launches First Breakeven Inflation ETFs

ProShares Launches First Breakeven Inflation ETFs

ProShares, the country’s fourth most successful exchange traded fund (ETF) company, 1 today announced the launch of ProShares 30 Year TIPS/TSY Spread (NYSE: RINF) and ProShares Short 30 Year TIPS/TSY Spread...

ProShares Names Stephen Sachs Head Of Capital Markets

ProShares, the nation’s fifth largest ETF provider, 1 announced today that Stephen Sachs has been named to the newly created role of head of capital markets.

ProShares ETFs Announce Zero Capital Gain Distributions

ProShares, the nation’s fifth largest ETF provider, 1 announced today that it expects that none of its 108 equity and fixed-income ETFs will pay any 2011 capital gain distributions.

ProShares Launches First Geared Natural Gas Futures ETFs

ProShares, a premier provider of alternative exchange traded funds (ETFs), today announced the launch of ProShares Ultra DJ-UBS Natural Gas (NYSE: BOIL) and ProShares UltraShort DJ-UBS Natural Gas (NYSE: KOLD), the...

ProShares Launches First Geared VIX Futures ETFs

ProShares, a premier provider of alternative exchange traded funds (ETFs), including the only VIX futures ETFs in the United States, today announced the expansion of its lineup with the launch of the first ETFs in the...

ProShares Launches ETF As Alternative To Hedge Funds

ProShares ®, a premier provider of alternative exchange traded funds (ETFs), today announced the launch of the ProShares Hedge Replication ETF (NYSE: HDG).

ProFunds Group® Names Troy Goldstein Director Of National Accounts

ProFunds Group, a premier provider of alternative ETFs and mutual funds, announced today that Troy Goldstein has been named to the newly created role of Director of National Accounts.

ProShares 130/30 ETF Surpasses $100 Million In Assets

ProShares, a premier provider of alternative exchange traded funds (ETFs), announced that the ProShares Credit Suisse 130/30 (NYSE: CSM), the nation’s only 130/30 ETF, has surpassed $100 million in assets.